Nyumbani › Magonjwa ya Mapafu ya Interstitial › Texas › Houston
Majaribio ya kliniki ya Magonjwa ya Mapafu ya Interstitial katika Houston, TX
Masomo 12 ya Magonjwa ya Mapafu ya Interstitial yanatafuta washiriki katika vituo vya Houston na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
InaajiriHatua 3
- Baylor College of Medicine, Houston
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
InaajiriHatua 3
- GSK Investigational Site, Houston
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
InaajiriHatua 2
- Baylor College of Medicine, Houston
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Inaajiri
- Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
InaajiriHatua 2
- Clinical Research Site, Houston
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
InaajiriUtafiti wa uchunguzi
- Houston Methodist, Houston
- University of Texas Health Science Center at Houston, Houston
Platform Clinical Study for Conquering Scleroderma
InaajiriHatua 2
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
InaajiriUtafiti wa uchunguzi
- Baylor College of Medicine, Houston
- Houston Methodist Lung Center, Houston
- The University of Texas Health Science Center At Houston, Houston
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
InaajiriHatua 2
- Houston Methodist Hospital, Houston
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
InaajiriHatua 3
- Houston Methodist Outpatient Center, Houston
- The University of Texas Health Science Center at Houston, McGovern Medical School, Houston
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
InaajiriUtafiti wa uchunguzi
- Baylor College of Medicine/Texas Children'S Hospital, Houston
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
InaajiriHatua 2
- aTyr Investigative Site, Houston
Majaribio ya Magonjwa ya Mapafu ya Interstitial katika miji mingine
- New York City, NYUtafiti 18
- Philadelphia, PAUtafiti 16
- Los Angeles, CAUtafiti 14
- Durham, NCUtafiti 13
- Kansas City, KSUtafiti 13
- Charleston, SCUtafiti 13
- Chicago, ILUtafiti 12
- Ann Arbor, MIUtafiti 11
- Aurora, COUtafiti 11
- Salt Lake City, UTUtafiti 9
- Phoenix, AZUtafiti 9
- Boston, MAUtafiti 9
Masomo mengine katika Houston
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 145
- Saratani ya MatitiUtafiti 126
- Saratani (aina zote)Utafiti 121
- Saratani ya MetastasiUtafiti 104
- Kansari ya kolorektaliUtafiti 102
- Kansari ya MayaiUtafiti 89
- Leukemia ya Myeloid ya GhaflaUtafiti 85
- Saratan ya MapafuUtafiti 78
- Saratani ya ProstateUtafiti 76
- Saratani ya EndometrialUtafiti 68
- Kansari ya PancreasUtafiti 61
- MelanomaUtafiti 59
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.